This leads to enhanced differentiation of naïve T-helper cells into effector T-helper/Memory cells [CD3+CD4+CD8α+CD8β-CD27-], which are capable of secreting high amounts of effector cytokines leading to efficient clearance of heterologous challenge virus at the site of infection. The gene discussed is CD8A; the disease is infection.